Who: we are a therapeutic platform company for natural products discovery. What: we identify low-toxicity, immune modulating, microbial metabolites. Why: we aim to treat chronic inflammatory diseases.
| Website | http://interface.bio |
| Employees | 2 (2 on RocketReach) |
| Founded | 2020 |
| Address | 2627 Hanover St, Palo Alto, California 94304, US |
| Industry | Biotechnology Research |
| Keywords | Therapeutic Platform, Immune Modulation, Chronic Inflammation, Natural Products, Inflammatory Diseases, Drug Discovery, Immunotherapy, Pharmaceutical Research, Biotechnology, Drug Development, Biologics, Small Molecule Drugs, Life Sciences, Precision Medicine, Rare Diseases, Clinical Trials |
| Competitors | ExxonMobil, BASF, Dow, 3M, DuPont, AkzoNobel, Celanese, Huntsman Corporation, COVESTRO ELASTOMERS SAS, Momentive +45 more (view full list) |
Looking for a particular Interface Biosciences employee's phone or email?
Will van Treuren is the Chief Scientific Officer and Co-Founder of Interface Biosciences.
2 people are employed at Interface Biosciences.
Interface Biosciences is based in Palo Alto, California.